DNB CTVS Questions- December 2010

DECEMBER 2010  

PAPER I
1.Enumerate deleterious effects of hypothermia on organ systems during      cardiopulmonary bypass. 10
2. Development of aortic arch with brief discussion on vascular ring. 10
3.  Classification o f mediastinum. Enumerate common tumours of each area. 10
4. process and criteria of sample size selection for a clinical study. 10
5. draw a labeled diagram and discuss the circulation changes that occur at the time of birth and their pathophysiological significance. 10
6. discuss in brief with labeled diagrams various surgical modalities in the management of  atrial fibrillation. 10
7.  enumerate neuroprotective strategies and their use in various surgical operations. Highlight use of one strategy of your choice. 10
8. diagnosis and management of heparin induced thrombocytopenia. 10
9. development of left superior vena cava and its implications during cardiac surgery. 10
10. diagnosis and cardiovascular manifestations of Marfan’s disease. 10
DECEMBER 2010   PAPER II
1. Aetiopathogenesis of thoracic outlet syndrome. 10
2. Presentation and surgical management of sequestration of lung. 10
3. Classification and surgical management (in brief) of tricuspid atresia.10
4. Classification and surgical management (in brief) of truncus arteriosus. 10
5. Pulmonary vascular disease and its investigation and grading.10
6. Mitral Valve Replacement – advantages of total chordal preservation and comparison with other techniques. 10
7. Coronary artery bypass- comparison of radial, saphenous vein and internal thoracic artery in term of histopathology and long term outcome. 10
8. Classification of thoraco-abdominal aortic aneurysms and role of endovascular interventions in their management. 10
9. Explain with diagram different surgical procedures for the management of small aortic root and comparative chart of their advantages and disadvantages. 10
10. Basic component and modifications of myocardial protection. 10

DECEMBER 2010   PAPER III
1. Cell sources for cardiac tissue engineering. 10
2. Centrifugal pump: advantages and disadvantages of its use in assisted circulation. 10
3. “No flow” phenomenon in myocardial ischemia.10
4. Computed tomography in re-operative cardiac surgeries and its role in pre operative planning and surgical guidance. 10
5. Role of hybrid operative interventions in cardiovascular surgery. 10
6. Current status  of cardiac transplantation. 10
7. Power source, current status and future development of artificial heart. 10
8. Newer oral anticoagulants and their role in DVT, AF, and Cardiological interventions. 10
9. Advantages and disadvantages of Virtual bronchoscopy. 10
10. Percutaneous valve implantation- in various positions, evolutions and future direction. 10

DNB CTVS Question- December 2012

DECEMBER 2012    

PAPER I
1. Discuss Jones criteria for diagnosis of rheumatic fever and current rheumatic fever prophylaxis guidelines.  4+6
2. Illustrate the surgical anatomy of the aortic root. Briefly describe patient- prosthesis mismatch. Draw labeled diagrams to show methods of aortic root enlargement. 3+2+5
3. Define renovascular hypertension. Describe its pathophysiology and treatment modalities. 2+(4+4)
4. Draw a labeled diagram to show fetal circulation. What are the immediate changes that occur soon after birth and why do they occur? 5+5
5. Discuss the roles of trans-thoracic and transesophageal echo in heart surgeries. 5+5
6. Discuss empyema thoraciswith respect to definition, etiology and management. 1+4+5
7. Mention the grades of pulmonary arterial hypertension. What are the methods of accessing the severity and reversibility of pulmonary arterial hypertension in children with congenital heart disease? 2+(5+3)
8. Discuss development of diaphragm, its surgical anatomy and management of hernia of Bochdalek.  4+3+3
9. Discuss in brief stem cell therapy in peripheral and myocardial angiogenesis with reference to     (a) source of stem cells         (b)methods of delivery with advantage and disadvantageof each method. 4+(3+3)
10. Can Tetralogy of Fallot (T.O.F) be called a monology? Justify your answer. Describe with diagram(s) the development of interventricular septumand right-ventricular outflow tract and describe what happens in T.O.F.  3+7
DECEMBER 2012     PAPER  II
1. Describe the concept and relevance of intracoronary shunts and stabilizers used in OPCAB. 4+3+3
2. Explain physiology of Fontan’s principle. Briefly describe the evaluation of Fontan’s operation and its current indications. 2+(4+4)
3. Describe the surgical anatomy of coronary arterial circulation.3
Discuss the rationale, advantages and limitations of retrograde coronary cardioplegia. 1+3+3
4. Describe the pathophysiology of ischemic mitral regurgitation. Discuss in brief the medical, surgical and percutaneous approaches to the disease. 4+(1+3+2)
5. Enumerate the drugs used, their role and results in thrombolytic treatment in prosthetic valve thrombosis. 2+4+4
6. Discuss the etiopathogenesis and management of acquired bronchopleural fistula. 3+7
7. Discuss the etiopathology and investigations for chronic constrictive pericarditis. What is post pericardiotomy syndrome? Briefly describe its management. 4+4+2
8. Classify and illustrate the lymph node stations in relation to the bronchogenic carcinoma. 10
9. Describe the risk factors for developing paraplegia during coarctation of aorta repair and management to prevent it. 5+5
10. Discuss the pathophysiology and  importance of pulmonary veins and left atrial enlargement in the genesis of atrial fibrillation in valvular heart disease and role of surgical intervention. 10

DECEMBER 2012     PAPER III
1. Discuss TAVI with regards to : a) indications and valves used               b) approach routes and              c) complications 3+4+3
2. Define and  classify heart failure. Discuss current status of destination therapy in surgical management of chronic heart failure. (2+2)+6
3. Briefly describe the concept of “Tissue engineered heart valves” and the current status of heart valve banking and heart valve institutes in India. 4+3+3
4. Define “ Internet and Communication Technology (I.C.T)” and comment on the impact of I.C.T in remote patient monitoring and health outcomes in cardiac surgical patients. 10
5. Define acute coronary syndrome. Discuss in brief indications of CABG in acute coronary syndrome and pathophysiology of “no-reflow phenomenon” 2+(3+5)
6. What are enabling devices? Briefly describe the role of enabling devices in cardiac surgery. 3+7
7. Define “counter-pulsation”. Describe physiological basis of IABP. What are its indications and complications? 2+3+(3+2)
8. Describe the concept of heart team. How do you think it will impact the future of CABG in India? 2+8
9. When is myocardial viability tests indicated? Discuss in brief the current modalities available for this test. 2+8
10. Discuss syntax trial under the following headings:
a) Design of the trial       b) outcome of the trial
c) Impact on current practice of stenting and CABG  4+4+2